semaglutide for menopause weight gain GLP-1s, Obesity, and Menopause: Benefits and Risks GLP-1 for Menopause Weight Gain:

Purpose-built for physicians GLP-1 use before weight-loss surgery rising, not linked to harmful outcomes Key takeaways: The use of GLP-1 receptor agonists in the year before weight-loss surgery rose more than threefold between 2018 and 2023

If additional glycemic control is needed after at least 4 weeks on the 0.5 mg dosage, the dosage may be increased to 1 mg once weekly

Tyrosinase-aided protein cross-linking: effects on gel formation of chicken breast myofibrils and texture and water-holding of chicken breast meat homogenate gels

See the graph (taken from the Lancet Neurology publication): A subgroup analysis raised the possibility of some motor benefits in younger participants

E.TengJ.FotopoulosM.RoumeliotisT